外体疗法:一种用于提高更年期前期雌激素水平的新方法
Samar Alkhrait1,2, Mervat M Omran1,3, Mohammad Mousaei Ghasroldasht1
1Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
International journal of molecular sciences
|July 13, 2024
概括
新型外体组疗法显示出对绝经前期的前景. 这种治疗刺激了卵巢组织中的天然雌激素的产生,为激素替代疗法 (HRT) 提供了潜在的非激素替代方案,并提高了安全性.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 绝经前期带来了重大的全球健康挑战,激素替代疗法 (HRT) 是一种常见但有风险的管理策略.
- 现有的经更年期症状治疗方法通常涉及荷尔蒙疗法,需要探索更安全的非荷尔蒙替代品.
- 经更年期期间卵巢功能下降导致雌激素水平降低和相关症状.
研究的目的:
- 调查外体治疗作为一种新型非激素治疗绝经前期症状的疗效.
- 为了确定从人类带介质干细胞中获得的外体细胞是否可以刺激卵巢组织中的雌激素生产.
- 评估外体治疗作为HRT更安全的替代品的潜力.
主要方法:
- 来自绝经前妇女的卵巢皮层样本的ex vivo培养.
- 使用来自人类带介质干细胞的cGMP产生的外体进行治疗.
- 通过ELISA量化雌激素水平,通过qPCR进行基因表达分析 (ERα,FSHR),并通过IHC评估细胞增殖/细胞亡.
主要成果:
- 与对照人群相比,异位细胞处理的卵巢组织中雌激素水平显著增加.
- 雌激素受体α (Erα) 的表达升高和细胞增殖标志物的增加.
- 在接受治疗的组织中观察到减少了亡标志物,这表明加强了组织活力.
结论:
- 外体疗法有效地增强了绝经前期卵巢组织中的雌激素生产和受体敏感性.
- 这种方法代表了HRT的有希望的非激素替代方案,用于管理更年期前症状.
- 外体疗法与自然调节机制保持一致,可能提供更安全,更有效的治疗方法.
更多相关视频
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
1.7K
08:07Preparation of Herbal Medicine: Er-Xian Decoction and Er-Xian-containing Serum for In Vivo and In Vitro Experiments
Published on: May 31, 2017
11.0K
相关概念视频
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:28Menopause
153
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
153
02:07Oogenesis
63.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.6K